Department of Gynecology, Dongying People's Hospital, Dongying, China.
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1250-1260. doi: 10.26355/eurrev_202102_24829.
This research intended to explore the expression and molecular mechanism of miR-34a-5p and Tripartite motif-containing protein 44 (TRIM44) in ovarian cancer (OC).
Tissue and serums of OC patients were collected, and miR-34a-5p and TRIM44 in serum and tissue were tested by Real-time quantitative PCR (qRT-PCR). In vitro cell experiment was constructed. Methyl Thiazolyl Tetrazolium (MTT), transwell, and flow cytometry were applied to test the proliferation, migration, invasion, and apoptosis. Western blot was performed to explore TRIM44 and epithelial-mesenchymal transition (EMT) proteins.
MiR-34a-5p was low expressed, while TRIM44 was highly expressed, which was related to Federation International of Gynecology and Obstetrics (FIGO) staging and lymph node metastasis. The receiver operating characteristic curve (ROC) revealed that the Area Under Curve (AUC) of miR-34a-5p and TRIM44 were 0.885 and 0.868, respectively. An evident increase of miR-34a-5p or decrease of TRIM44 could inhibit OC malignant behaviors, and E-cadherin increased while N-cadherin and Fibronectin decreased. The knockdown of miR-34a-5p or overexpression of TRIM44 could inhibit the malignant behavior of ovarian cancer cells, hinder the malignant behaviors, and reduce E-cadherin, while N-cadherin and Fibronectin protein was enhanced. Co-transfection found that overexpression of miR-34a-5p eliminated the biological behaviors of OC cells by TRIM44.
MiR-34a-5p and TRIM44 can be used as diagnostic markers for OC. MiR-34a-5p can act in biological behaviors by targeting TRIM44 in OC.
本研究旨在探讨微小 RNA-34a-5p(miR-34a-5p)和三结构域蛋白 44(TRIM44)在卵巢癌(OC)中的表达及分子机制。
收集 OC 患者的组织和血清,采用实时定量 PCR(qRT-PCR)检测血清和组织中的 miR-34a-5p 和 TRIM44。构建体外细胞实验。采用甲基噻唑基四唑(MTT)、Transwell 和流式细胞术检测细胞增殖、迁移、侵袭和凋亡。Western blot 检测 TRIM44 和上皮间质转化(EMT)蛋白。
miR-34a-5p 低表达,TRIM44 高表达,与国际妇产科联合会(FIGO)分期和淋巴结转移有关。受试者工作特征曲线(ROC)显示,miR-34a-5p 和 TRIM44 的曲线下面积(AUC)分别为 0.885 和 0.868。miR-34a-5p 明显增加或 TRIM44 明显减少可抑制 OC 恶性行为,E-钙黏蛋白增加,而 N-钙黏蛋白和纤连蛋白减少。miR-34a-5p 敲低或 TRIM44 过表达可抑制卵巢癌细胞的恶性行为,抑制恶性行为,降低 E-钙黏蛋白,同时增强 N-钙黏蛋白和纤连蛋白蛋白。共转染发现,过表达 miR-34a-5p 通过 TRIM44 消除 OC 细胞的生物学行为。
miR-34a-5p 和 TRIM44 可作为 OC 的诊断标志物。miR-34a-5p 可通过靶向 TRIM44 作用于 OC 的生物学行为。